Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 4371326: Novel Role of Copper Transporter CTR1 in VEGF-C-induced VEGFR3 Signaling and Lymphangiogenesis

View through CrossRef
Background: VEGF-C is a central regulator of lymphangiogenesis, the formation of new lymphatic vessels, by binding to VEGFR-3 on lymphatic endothelial cels (LECs), triggering signaling pathways promoting their migration, and forming new lymphatic vessels. While we reported that reactive oxygen species (ROS) from NADPH oxidases (NOXs) and mitochondria, as well as physiological copper (Cu) levels regulated by the Cu uptake transporter CTR1, are important in angiogenesis, their roles in VEGF-C-induced VEGFR3 signaling and lymphangiogenesis remain unknown. Results: Here we show that VEGF-C stimulation induced a biphasic ROS response in human LECs, an early transient increase within 30 min and a sustained late-phase elevation up to 4 hrs. Overexpression of mitochondria-targeted catalase (mito-catalase), but not NOX4 knockdown, suppressed both VEGF-C-induced ROS production and key lymphangiogenic responses including EC proliferation (1.9 fold), migration (2.5 fold), and tube formation (1.2 fold), indicating a predominant role for mitochondrial ROS (mitoROS). Mito-catalase also attenuated VEGFR3 phosphorylation and downstream ERK1/2 and Akt activation. We then examined the role of Cu and CTR1 and found that CTR1 knockdown significantly impaired VEGF-C-induced VEGFR3, ERK1/2, and Akt phosphorylation, late-phase ROS production, and lymphangiogenic responses without affecting early ROS generation. In contrast, Cu chelation with BCS inhibited late-phase ROS and lymphangiogenesis without affecting VEGFR3 activation, suggesting a Cu-independent role of CTR1 in initiating VEGFR3 signaling. Mechanistically, VEGF-C promoted rapid CTR1-VEGFR3 association and co-internalization within 30 min, supporting receptor activation and sustained ROS generation. In vivo, VEGF-C-induced lymphangiogenesis and inflammatory cell recruitment (Lyve1+, VEGFR3+, and CD45+ cells) were significantly diminished in Ctr1 +/- mice using a Matrigel plug model. Conclusion: These findings uncover a novel biphasic mechanism whereby VEGF-C promotes lymphangiogenesis through mitoROS-CTR1-VEGFR3 axis which initiates VEGFR3 signaling independent of Cu, followed by Cu-dependent ROS amplification to sustain downstream migration and tube formation. This study reveals CTR1 as a critical regulator of VEGFR3 signaling and lymphatic vessel formation.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 4371326: Novel Role of Copper Transporter CTR1 in VEGF-C-induced VEGFR3 Signaling and Lymphangiogenesis
Description:
Background: VEGF-C is a central regulator of lymphangiogenesis, the formation of new lymphatic vessels, by binding to VEGFR-3 on lymphatic endothelial cels (LECs), triggering signaling pathways promoting their migration, and forming new lymphatic vessels.
While we reported that reactive oxygen species (ROS) from NADPH oxidases (NOXs) and mitochondria, as well as physiological copper (Cu) levels regulated by the Cu uptake transporter CTR1, are important in angiogenesis, their roles in VEGF-C-induced VEGFR3 signaling and lymphangiogenesis remain unknown.
Results: Here we show that VEGF-C stimulation induced a biphasic ROS response in human LECs, an early transient increase within 30 min and a sustained late-phase elevation up to 4 hrs.
Overexpression of mitochondria-targeted catalase (mito-catalase), but not NOX4 knockdown, suppressed both VEGF-C-induced ROS production and key lymphangiogenic responses including EC proliferation (1.
9 fold), migration (2.
5 fold), and tube formation (1.
2 fold), indicating a predominant role for mitochondrial ROS (mitoROS).
Mito-catalase also attenuated VEGFR3 phosphorylation and downstream ERK1/2 and Akt activation.
We then examined the role of Cu and CTR1 and found that CTR1 knockdown significantly impaired VEGF-C-induced VEGFR3, ERK1/2, and Akt phosphorylation, late-phase ROS production, and lymphangiogenic responses without affecting early ROS generation.
In contrast, Cu chelation with BCS inhibited late-phase ROS and lymphangiogenesis without affecting VEGFR3 activation, suggesting a Cu-independent role of CTR1 in initiating VEGFR3 signaling.
Mechanistically, VEGF-C promoted rapid CTR1-VEGFR3 association and co-internalization within 30 min, supporting receptor activation and sustained ROS generation.
In vivo, VEGF-C-induced lymphangiogenesis and inflammatory cell recruitment (Lyve1+, VEGFR3+, and CD45+ cells) were significantly diminished in Ctr1 +/- mice using a Matrigel plug model.
Conclusion: These findings uncover a novel biphasic mechanism whereby VEGF-C promotes lymphangiogenesis through mitoROS-CTR1-VEGFR3 axis which initiates VEGFR3 signaling independent of Cu, followed by Cu-dependent ROS amplification to sustain downstream migration and tube formation.
This study reveals CTR1 as a critical regulator of VEGFR3 signaling and lymphatic vessel formation.

Related Results

Non-canonical regulation of the plasma membrane copper transporter CTR1 through modulation of membrane mechanical properties
Non-canonical regulation of the plasma membrane copper transporter CTR1 through modulation of membrane mechanical properties
We describe a non-canonical, membrane receptor-like regulation of the human copper transporter CTR1 in response to copper stimuli. CTR1 is the sole high-affinity trimeric plasma-me...
Abstract 1817: Resistin induces angiogenesis and lymphangiogenesis in human chondrosarcoma
Abstract 1817: Resistin induces angiogenesis and lymphangiogenesis in human chondrosarcoma
Abstract Chondrosarcoma is a common kind of bone cancers, and it may develop distant metastasis, followed by a significant decline in overall survival. However, ther...
Abstract 3209: Everolimus inhibits angiogenesis and lymphangiogenesis to affect tumor growth in TP53 mutant HNSCC
Abstract 3209: Everolimus inhibits angiogenesis and lymphangiogenesis to affect tumor growth in TP53 mutant HNSCC
Abstract Head and neck squamous cell carcinoma (HNSCC) constitutes the eighth most common cancer globally, with the eighth highest mortality rate amongst all cancer ...
Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2
Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2
Abstract Purpose: Tumor progression correlates with the induction of a dense supply of blood vessels and the formation of peritumoral lymphatics. Hemangiogenesis and...
Data from The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
Data from The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
<div>Abstract<p><b>Purpose:</b> Lymphangiogenesis, the growth of lymphatic vessels, contributes to lymphatic metastasis. However, the precise mechanism unde...
Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications
Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications
ABSTRACT Despite the recent advances in treatment, breast cancer (BCa) remains a leading cause of cancer‐related mortality worldwide, and metastasis accounts for ...
VEGF Receptor Signal Transduction
VEGF Receptor Signal Transduction
The family of vascular endothelial growth factors (VEGFs) currently includes VEGF-A, -B, -C, -D, -E, and placenta growth factor (PlGF). Several of these factors, notably VEGF-A, ex...

Back to Top